Organogenesis Holdings (ORGO) Shares Outstanding (Weighted Average) (2015 - 2026)

Organogenesis Holdings' Shares Outstanding (Weighted Average) history runs 12 years deep, the most recent figure standing at $127.8 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 1.19% year-over-year to $127.8 million; the TTM figure through Mar 2026 stood at $127.8 million (up 1.19% YoY), while the FY2025 annual figure was $126.7 million, down 3.75% from the prior year.
• Shares Outstanding (Weighted Average) was $127.8 million for Q1 2026 at Organogenesis Holdings, up from $126.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $132.3 million in Q3 2024 to a low of $126.3 million in Q1 2025.
• Historically, Shares Outstanding (Weighted Average) has averaged $129.8 million across 5 years, with a median of $130.9 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) advanced 1.83% in 2022, then retreated 4.22% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $130.1 million in 2022, then rose by 0.89% to $131.2 million in 2023, then increased by 0.34% to $131.7 million in 2024, then retreated by 3.75% to $126.7 million in 2025, then climbed by 0.84% to $127.8 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $127.8 million (Q1 2026), $126.7 million (Q4 2025), and $126.9 million (Q3 2025), per Business Quant data.